Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HCV Reinfection in Incarcerated Population (SAIL-001)
NCT02460133Phase 4Active, not recruiting
- Sponsor
- Nova Scotia Health
- Start
- Jul 2015
- Primary completion
- Oct 2025
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of Viekira Pak in Hepatitis C genotype 1, sponsored by Nova Scotia Health. Started Jul 2015; status: active, not recruiting.
02
Drugs
Viekira Pak
03
Conditions
Hepatitis C genotype 1
Beyond the preview
Go deeper on NCT02460133.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02460133.